阿片类药物诱导的长QT综合征:对心脏健康的挑战
Jiale Hu1, Yongfei Song1,2, Xiaoyan Huang1,2
1Department of Cardiology, Ningbo University Health Science Center Affiliated Lihuili Hospital, Ningbo University, Zhejiang, China.
Cardiovascular toxicology
|April 17, 2024
概括
过量服用阿片类药物带来了除呼吸抑制之外的风险,包括危险的心律变化. 了解阿片类药物心脏毒性和药物离子通道相互作用对于患者安全和干预至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 毒理学 毒理学 毒理学
背景情况:
- 过量服用阿片类药物是由于临床使用和滥用而引起的重大健康问题.
- 目前的重点是呼吸道和幻觉效应,忽略了心脏毒性.
- 阿片类药物可以延长QT间隔,导致心律失常和突然死亡.
研究的目的:
- 探索阿片类药物和心律失常之间的联系.
- 为了确定阿片类药物诱导心脏毒性的治疗点.
- 了解阿片类药物对离子通道和QT间隔延长的影响.
主要方法:
- 关于阿片类药理学和心脏毒性科学文献的综述.
- 对药物离子通道相互作用的分析.
- 研究QT间隔延长背后的机制.
主要成果:
- 大多数阿片类药物可以延长QT间隔.
- 这种延长增加了严重心室节律失常的风险.
- 了解药物离子通道相互作用是管理风险的关键.
结论:
- 阿片类药物的心脏毒性,特别是QT延长,是过量服用的关键但经常被忽视的方面.
- 需要对阿片类药物离子通道相互作用进行进一步的研究.
- 这些知识可以指导干预措施,以减轻与阿片类药物使用相关的风险.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
988
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
988
Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
741
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
741
Analgesia and Pain Management
614
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
614
Mechanism of Cardiac Arrhythmias
918
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
918


